顯示具有 Medicine-Gastroenterology and Hepatology-Hepatocellular Carcinoma 標籤的文章。 顯示所有文章
顯示具有 Medicine-Gastroenterology and Hepatology-Hepatocellular Carcinoma 標籤的文章。 顯示所有文章

星期三, 5月 21, 2014

Hepatocellular Carcinoma: Clinical Frontiers and Perspectives

Recent Advances in Clinical Practice

Background
Hepatocellular Carcinoma (HCC) is a major health concern:
1. Over 700,000 cases are diagnosed annually
2. One of the leading causes of cancer-related death
3. Main event leading ot deaeth in patients with cirrhosis

Risk Factors:
1. HBV
2. HCV
3. Alcohol-related cirrhosis
4. Non-alcoholic steatohepatitis
5. Smoking
6. Metabolic syndromes?
7. Coffee may diminish risk

Molecular Events: What Have We Learned?
Expectations from the biomedical community for genetic studies:
1. Easily risk-stratify patients
    A. Risk for developing HCC
    B. Risk for HCC recurrence following "curative: therapy
    C. Disease prognostication for existing HCC
2. Identify common and dominant oncogenic pathways
    A. Carcinogenesis
    B. Invasion and metastases
3. Institute targeted and curative therapies using a personalised medicine approach